IMPACT OF ENOXAPARIN ON ANTIXA LEVELS WHEN TRANSITIONING TO UNFRACTIONATED HEPARIN INFUSION

被引：0
|
作者：
Graham, Miranda [1 ]
Linkhorst, Amber [2 ]
Andrick, Laura [1 ]
机构：
[1] Geisinger Med Ctr, Danville, PA USA
[2] Lehigh Valley Hlth Network, Allentown, PA USA
来源：
CRITICAL CARE MEDICINE | 2024年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
1208
引用
收藏
页数：1
相关论文
共 50 条
  • [1] COMPARISON OF THE PHARMACOKINETICS OF ENOXAPARIN (CLEXANE) AND UNFRACTIONATED HEPARIN
    DAWES, J
    ACTA CHIRURGICA SCANDINAVICA, 1990, : 68 - 74
  • [2] Transitioning hospitalized patients from rivaroxaban or apixaban to a continuous unfractionated heparin infusion: A retrospective review
    Smith, Alex R.
    Dager, William E.
    Gulseth, Michael P.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2020, 77 : S59 - S65
  • [3] Consistent therapy with enoxaparin is superior to unfractionated heparin in SYNERGY
    Mahaffey, KW
    Califf, RM
    Cohen, M
    Pieper, KS
    White, HD
    Traylor, L
    Ferguson, JJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 231A - 231A
  • [4] Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa
    Lewis, Joseph
    Iqbal, Omer
    Jeske, Walter
    Hoppensteadt, Debra
    Siddiqui, Fakiha
    Fareed, Jawed
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [5] Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa
    Lewis, Joseph
    Iqbal, Omer
    Jeske, Walter
    Hoppensteadt, Debra
    Siddiqui, Fakiha
    Fareed, Jawed
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [6] Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa
    Lewis, Joseph
    Iqbal, Omer
    Jeske, Walter
    Hoppensteadt, Debra
    Siddiqui, Fakiha
    Fareed, Jawed
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [7] Enoxaparin vs unfractionated heparin in acute coronary syndrome
    Kanna, B
    Sharma, P
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (16): : 1952 - 1952
  • [8] Challenges of anticoagulation therapy in children: UFH contamination of enoxaparin antiXa levels when drawn through a central line
    Massicotte, M. P.
    Bauman, M. E.
    Bauman, M. L.
    Black, K. L.
    Bajzar, L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 471 - 472
  • [9] No clinically relevant interaction between sugammadex and heparin (enoxaparin and unfractionated heparin) on coagulation
    Kruithof, A.
    De Kam, P. J.
    El Galta, R.
    Moerland, M.
    Kluft, C.
    Van Lierop, M. J.
    Dennie, J.
    Troyer, M.
    Gutstein, D.
    Burggraaf, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1091 - 1092
  • [10] Intravenous enoxaparin versus unfractionated heparin in unselected patients undergoing percutaneous coronary interventions: the Zurich enoxaparin versus unfractionated heparin in PCI study (ZEUS)
    Bertel, Osmund
    Ramsay, David
    Wettstein, Tobias
    Kurz, David J.
    Stettler, Irene
    Straumann, Edwin
    Frielingsdorf, Juergen
    Maurer, Dominik
    Naegeli, Barbara
    EUROINTERVENTION, 2010, 6 (03) : 407 - 412
12345